What we do Suraksha Diagnostic Ltd operates integrated pathology, radiology and omnichannel medical consultation services through 55 diagnostic centers in East India, offering 3300+ testing profiles. |
Founded in 2,005 |
Market share Largest integrated diagnostic chain in East India by operating income with expanding footprint in West Bengal and neighboring states. |
Problem solved Addresses need for accessible, accurate, and affordable diagnostic and consultation services with advanced testing technologies and digital convenience. |
Top clients or who we serve B2C and B2B customers including hospitals and group insurance clients across West Bengal, Bihar, Assam, Meghalaya. |
Key management Dr. Somnath Chatterjee (Chairman & Joint MD), Ritu Mittal (Joint MD & CEO), with experienced finance and operations executives. |
Our journey and innovations Started in 2005, rapidly expanded to 55 centers by 2025, included genomic medicine via acquisition, and established hub-and-spoke model with NABL and CAP accreditations. |
Where we operate Primarily in West Bengal, expanded to Bihar, Assam, Meghalaya in East and Northeast India. |
Top products or what we offer Comprehensive pathology and radiology tests, medical consultations, home collection, advanced imaging like 3T MRI, 128 CT scans, and genomic testing services. |
Top brands Suraksha Diagnostic, Suraksha Genomics, Fetomat Wellness (subsidiary for fetal and maternal diagnostics). |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue largely recurring from diagnostic tests and medical consultations with steady demand growth. |
Our industry position Leading position in Eastern India diagnostics market, capitalizing on growing organized healthcare and diagnostic market segment. |
Financial highlights FY25 Revenue ₹2520 million, PAT ₹310 million; consistent growth with 33.8% EBITDA margin and 12.3% PAT margin. |
Geographical revenue split 95.5% revenue from West Bengal, rest from Bihar, Assam, Meghalaya. |
Order book - |
Whats driving growth Expansion of diagnostic centers, genomic medicine launch, technology upgrades, increased consultations, and PPP models with government. |
Our future plans Open 6 more centers by FY26 end, scale genomic services, leverage hub-spoke and polyclinic models for growth. |
Our green promise - |
Our people and values Focus on employee wellbeing with 360° growth, ethical governance, and high customer satisfaction standards. |
Key challenges ahead Scaling operational efficiencies amid rapid expansion, technology integration, and competition from regional chains. |
Interesting facts First 3T MRI and 128 CT scan launched in New Town; successful IPO raised over ₹846 crore in 2024. |
Risks and strategy Risk mitigated via technological investments, cluster-based model, focus on quality accreditations, and diversified revenue streams. |
